SCHEMBL21396673

SCHEMBL21396673

N#Cc1cccc(-n2c3ccccc3c3ccccc32)c1-c1ccc(-n2c3ccccc3c3ccccc32)cn1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A9 P48067 1/20 0.36
KDM4E B2RXH2 1/20 0.36
ATM Q13315 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
USP14 P54578 1/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
CA1 P00915 1/20 0.34
CA2 P00918 1/20 0.34
HIF1A Q16665 1/20 0.34
SLC2A1 P11166 2/20 0.34
SLC2A3 P11169 2/20 0.34
SLC2A2 P11168 1/20 0.34
IMPDH2 P12268 1/20 0.33
ALDH1A1 P00352 3/20 0.33
MAPT P10636 1/20 0.32
SLC6A3 Q01959 1/20 0.32
HPGD P15428 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
PTGER4 P35408 1/20 0.32
STAT3 P40763 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17955024 0.83 ATM (0.39) KDM4EATML3MBTL1USP14SMN1; SMN2
SCHEMBL19062208 0.82 CA1 (0.44) KDM4EATML3MBTL1SMN1; SMN2CA1
SCHEMBL19755307 0.81 KDM4E (0.43) KDM4EATML3MBTL1USP14SMN1; SMN2
SCHEMBL21396668 0.81 KDM4E (0.35) SLC6A9KDM4EATML3MBTL1USP14
SCHEMBL21396982 0.81 ALDH1A1 (0.39) SLC6A9KDM4EATML3MBTL1USP14
SCHEMBL19062219 0.80 CA1 (0.43) KDM4EATML3MBTL1SMN1; SMN2CA1
SCHEMBL22378596 0.80 KDM4E (0.42) KDM4EATML3MBTL1SMN1; SMN2CA1
SCHEMBL21397069 0.80 ALDH1A1 (0.39) SLC6A9KDM4EATML3MBTL1USP14
SCHEMBL22729266 0.79 KDM4E (0.35) KDM4EATML3MBTL1SMN1; SMN2IMPDH2
SCHEMBL21396983 0.78 ALDH1A1 (0.38) KDM4EATML3MBTL1USP14SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3543230-B1 ORGANIC ELECTROLUMINESCENCE DEVICE AND POLYCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE SAMSUNG DISPLAY CO LTD (KR) 2021-05-05 EP disclosed
US-20190296247-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND POLYCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2019-09-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190296247-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND POLYCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE SLC25A21, SLCO4C1, SLC18A1 SLC6A9 233/4885KDM4E 955/4885ATM 4028/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.